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Reactions of optically pure P-stereogenic ortho-tolyl substituted phosphines with [RuCl2(p-cymene)]2 41 
afforded the corresponding kP-coordinated ruthenium(II) dichlorides (C1′, C2’) even in the presence of 42 
sodium acetate. In contrast, the ruthenium cyclometallated (k2-C,P) complexes (C3eC9) were obtained 43 
with phosphines containing a polycyclic aromatic substituent (L3-L9), namely 1-naphthyl, 9-44 
phenanthryl or 1-pyrenyl. Some diastereoselectivity in the cyclometallation process has been observed 45 
for the most bulky ligands. The new compounds have been used as catalytic precursors in the reduction 46 
of acetophenone to 1-phenylethanol by transfer hydrogenation. 47 
 48 
49 
1. INTRODUCTION 50 
 51 
The cyclometallation reaction is a transition metal CeH activation to form a metallacyle containing a 52 
new metal-carbon s-bond. This reaction can be split into two main processes: the coordination of the 53 
heteroatom of the ligand to the metal and, in a second step, activation of one of the CeH bonds of the 54 
ligand [1]. 55 
Cycloruthenation is an extremely versatile process and shows a broad scope [2], and cyclometallated 56 
ruthenium compounds have been used as catalysts in different reactions including reduction of ketones 57 
and aldehydes [3], olefin metathesis [4], CeC bond formation reaction [5], hydrogenation [6], and ortho-58 
deuteration [7]. In addition to this, some cycloruthenated derivatives have been shown to display 59 
interesting antitumour activities [8] and also promising photophysical and electrochemical properties 60 
[9]. In recent years, the ruthenium catalyzed ortho- or even meta-  C H bond functionalizations have 61 
become a thriving research area [10]. 62 
Despite the long history of P-stereogenic ligands, they are relatively rare in the literature because of their 63 
cumbersome synthesis [11]. The last two decades, however, have witnessed a renaissance in the field 64 
with the appearance of new methods amenable for the synthesis of such compounds [12]. 65 
Our group has worked with several types of chiral phosphines and with the corresponding palladium and 66 
ruthenium complexes that have been used in catalytic hydrovinylation (Pd) [13], allylic substitution (Pd) 67 
[13d,14], cyclopropanation (Ru) [15] and transfer hydrogenation (Ru) [13d,15,16] reactions. 68 
Recently, a paper of Zhu and coworkers described the synthesis, structure, reactivity and catalytic 69 
activity of cyclometallated ruthenium complexes with phosphines containing the 1-naphthyl or the 2-70 
tolyl groups [17]. They carried out the cyclometallation reaction under very mild conditions in the 71 
presence of sodium acetate forming neutral, Ru-stereogenic complexes that were obtained as racemic 72 
mixtures since the phosphines used were achiral. 73 
The aim of the present paper is to present the results obtained using Zhu's method to cyclometallate 74 
chiral optically pure P-sterereogenic phosphines (L1-L9) developed previously in the group containing 75 
potentially cyclometallating groups (2-tolyl, 1-naphthyl, 9-phenanthryl and 1-pyrenyl) in a process that 76 
allows the synthesis of non-racemic Ru-stereogenic derivatives. 77 
 78 
79 
2. RESULTS AND DISCUSSION 80 
 81 
2.1. Synthesis and characterisation of coordination compounds C10 and C2’ 82 
 T he P-stereogenic ligands (L1-L9) shown in Chart 1 were prepared via phosphine-boranes following 83 
 the Jug e-Stephan methodology as we have previously reported for ligands L3-L9 [13a,b14,16]. We 84 
here described the synthesis of phosphine L1 by deprotection of the known phosphine-borane L1·BH3 85 
[18]. Phosphine L2was obtained in low optical purity a long time ago [19] and in racemic form very 86 
recently [20]. We here report its first enantioselective synthesis via its previously not reported borane 87 
adduct, L2·BH3. P-stereogenic phosphines L1 and L2 could afford a fivemembered cyclometallated 88 
derivative by activation of the C(sp3)-H bond of the ortho-tolyl fragment. The cyclorutenation of this 89 
fragment have been described in the sterically demanding diisopropyl-(ortho-methylphenyl)phosphine, 90 
when this phosphine is treated with the organometallic precursor [RuCl2(p-cymene)]2 and sodium 91 
acetate [17]. The importance of the ortho-C-H bond deprotonation by carbonate [21] or carboxylate [22], 92 
as a proton shuttle to form a cyclometallated ruthenium(II) complexes has been recognised while some 93 
DFT calculations have shown that the CeH activation step involves a simultaneous metallation of the 94 
CeH bond and intramolecular deprotonation by acetate [23]. The beneficial effect of the bulkiness of 95 
phosphines in the cyclometallation process due to entropic factors has also been known for quite a long 96 
time [24]. 97 
With the idea of obtaining cyclometallated complexes C1 and C2, the organometallic precursor 98 
[RuCl2(p-cymene)]2 was reacted with slightly more than 2 equivalents of the ligand L1 or L2 (bearing 99 
the ortho-tolyl group), and sodium acetate in methanol (Scheme 1). The excess of ligand ensures that no 100 
ruthenium precursor, which would be very difficult to separate from C1 and C2, remained after the 101 
reaction. 102 
Despite many efforts at different sets of conditions, only the non-cyclometallated dichlorocomplexes C1′ 103 
and C2′ were obtained, which were characterised by 1H, 31P-{1H}, 13C-{1H} NMR spectra and high-104 
resolution mass spectroscopy. 31P-{1H} NMR spectroscopy is a very useful tool to determine if the 105 
cyclometallated compound has been formed [25]. Only a signal at 20 ppm and 40 ppm was observed in 106 
31P-{1H} NMR spectra for the reactions with L1 and L2 respectively. These chemical shifts are too low 107 
to correspond to the expected cyclometallated complexes C1 and C2 and show that dichlorocomplexes 108 
C1′, and C2’ were formed [13d,15,17] instead (Scheme 1). 109 
Suitable crystals of C1′ and C2’ were obtained from a dichloromethane-  hexane solution at 4 C and 110 
were analyzed by Xray diffraction (see Fig. 1). 111 
Right: Ball and stick representation of C2′ showing the labelling scheme; hydrogen atoms have been 112 
omitted for clarity. Selected  bond lengths [Å] and angles [ ]: Ru(1)eP(1) 2.3844(17), Ru(1)e Cl(1) 113 
2.4287(15), Ru(1)eCl(2) 2.4081(15), P(1)eC(11) 1.846(6); Ru(1)eP(1)eC(11) 109.27(19).P(1)-C(24) 114 
1.870(6). 115 
Both complexes form crystals that contain individual molecules separated by Van der Waal contacts. 116 
The molecules contain a pseudotetrahedral ruthenium centre coordinated to two chloride atoms, the 117 
phosphorus atom and the h6-p-cymene ring in the classical three-legged piano stool geometry, as 118 
commonly found for complexes of the type [Ru(h6-arene)Cl2(monophosphine)] [13d,15,17]. The 119 
phosphorus atomof the free phosphine would have the absolute configuration S in both molecules, 120 
according to the Cahn-Ingold-Prelog nomenclature system, as expected from the stereochemistry of the 121 
 Jug e-Stephan method and the enantiomer of ephedrine used [26]. The distances and angles of C1′ and 122 
C2’ are very similar and in the range for similar complexes. 123 
 124 
2.2. Synthesis and characterisation of cyclometallated compounds C3eC5 125 
After the unsuccessful preparation of C1 and C2, containing the cyclometallated ortho-tolyl group, our 126 
attention was shifted towards the synthesis of complexes C3eC5, containing the 1-naphthyl group. It has 127 
to be noted that the non-cyclometallated dichlorocomplexes C3′-C5′ have been reported in previous 128 
studies of our group [15]. The cyclometallation of these phosphines seems to be easier than the 129 
metallation of L1 or L2 since L3-L5 are more sterically demanding and because the metallacycle, in this 130 
case, would be formed by activation of a C(sp2)-H bond, an easier process than the activation of a 131 
C(sp3)-H bond of an ortho-methyl group. 132 
The organometallic precursor [RuCl2(p-cymene)]2 was reacted with slightly more than 2 equivalents of 133 
the ligands L3-L5 and with sodium acetate in methanol (Scheme 2). The signals observed in the 31P-134 
{1H} NMR spectra of the reaction mixtures (peaks at around 55, 75 and 160 ppm for the reactions with 135 
L1, L2 and L3 respectively) were strongly deshielded in relation to the signals of the corresponding 136 
previously reported dichlorocomplexes C3′-C5' (14.5, 30.3 and 166.6 ppm, respectively), pointing out 137 
that the cyclometallation reaction had taken place [15,25]. 138 
Complexes C3eC5 were indeed obtained pure as brown solids in around 15% yield, after purification by 139 
column chromatography. The low yields are probably due to partial decomposition of the complexes 140 
during the purification step since the analysis at short reaction times indicates that no other major 141 
species were present. NMR spectra and high-resolution mass spectroscopy of the complexes confirmed 142 
that the cyclometallation had taken place. 143 
The 31P-{1H} NMR spectrum consisted in two singlets in the case of C3′ and C5′ because of the 144 
formation of two diastereomers with different absolute configuration at the ruthenium atom. The 145 
diastereomeric ratios are 1:2.4 and 1:1.6 for C3 and C5 respectively. Interestingly, for complex C4, 146 
bearing the bulkiest phosphine L4, only one singlet was observed, indicating that the cyclometallation 147 





2.3. Synthesis and characterisation of cyclometallated compounds C6eC9 153 
We subsequently explored the cyclometallation of phosphines L6-L9, containing a 9-phenanthryl or 1-154 
pyrenyl groups, which could afford a five-membered metallacycle by activation of a C(sp2)-H bond 155 
(Scheme 3). 156 
The reactions were performed in the same conditions used for L3-L6 (see before). 31P-{1H} NMR 157 
spectra showed two peaks at low fields with respect of dichlorocomplexes, after 2 h of reaction, 158 
suggesting that the cyclometallations had taken place for all the phosphines. It should be noted that there 159 
is no precedent of Rucyclometallations with phosphines bearing those groups. 160 
The products were purified by column chromatography. The yields were very low (<8%), except for the 161 
C6, which was surprisingly obtained in 71% yield. The low yields are due, as previously mentioned, to 162 
decomposition during purification. It should also be noted that cyclometallated complexes with the 163 
phosphinites (C7 and C9) were especially prone to decomposition and for this reason they could not be 164 
fully characterised or used in catalysis. Unfortunately itwas not possible to study the complexes with the 165 
isopropyl  phosphines with these rings since Jug e-Stephan method does not allow to obtain the 166 
corresponding ligands due to steric problems [13a]. 167 
All of the most significant peaks discussed in the previous complexes appear duplicated at the 1H NMR 168 
spectra (Fig. 2), due to the formation of two diastereomers. It is remarkable the high field shift of one of 169 
the signals (d ¼ 4.13 ppm) which suggest a proximity between this proton and the phenyl moiety. In the 170 
31P-{1H}-NMR spectra the two expected peaks appeared, corresponding to the two diastereomeric 171 
species. The isomeric ratios were 1:3.2, 1:2.3, 1:2.6 and 1:2.8 for complexes C6eC9 respectively. 172 
From these results, it can be concluded that polycylic rings of the type 1-naphtyl, 9-phenantryl and 1-173 
pyrenyl are adequate to form cyclometallated ruthenium complexes. 174 
We were able to grow crystals suitable for X-ray measurements of C6, whose molecular structure is 175 
shown in Fig. 3. The structure confirms that the cyclometallation reaction had taken place by a C(sp2)-H 176 
activation of the 9-phenanthryl substituent of the phosphine. The molecules of the complex also exhibit 177 
the three-legged piano stool geometry, being the ruthenium atom coordinated to chloride, phosphorus 178 
and to the C11 of the 9-phenanthryl group atoms, forming a five membered metallacycle. Remarkably, 179 
the RueP bond distance [2.2825(9) Å] is much shorter than in C1′ and C2' [2.3640(6) and 2.3844(17) Å 180 
respectively] suggesting that the cyclometallation probably contributes to release the tension of the 181 
molecular structure. A very short Ru(1)-C(11) bond length [2.095(3) Å] is also present. This structure is 182 
very similar to others recently described with 1-naphthylphosphines, demonstrating that phosphines with 183 
fused aromatic polycyclic substituents are particularly prone to cyclometallation [17]. 184 
Ru(1)eP(1) 2.2825(9), Ru(1)eCl(1) 2.4197(8), Ru(1)eC(11) 2.095(3), P(1)eC(23) 1.805(3), C(23)eC(24) 185 
1.437(5), C(24)eC(11) 1.432(5); P(1)eRu(1)eCl(1) 87.82(3), P(1)eRu(1)eC(11) 80.42(10), 186 
C(11)eRu(1)eCl(1) 85.92(9), Ru(1)eP(1)eC(23) 105.26 (11). 187 
The free phosphine ligand has S absolute configuration, as expected and, remarkably, only one 188 
diastereomer of the complex is present in the crystal, with R absolute configuration at the ruthenium 189 
atom. Therefore, the crystal exclusively contains the (RRu,RP)-C6 isomer of the complex (the descriptor 190 
of the absolute configuration of the phosphorus atom changes due to coordination with respect to the 191 
free ligand), despite the fact that (SRu,RP)-C6 is also present in solution according to NMR. This could 192 
be due to the higher insolubility of the RRu diastereomer, or that the selected crystal contained this 193 
isomer while others contain the SRu or finally, although unlikely, it can not be excluded that the two 194 
diastereomers are in equilibrium and that there is a dynamic resolution process producing only the 195 
(RRu,RP)-C6 in the solid state. It  has to be pointed out that the crystal was very difficult to obtain due 196 
to the instability and low crystallinity of C6 and for this reason the analysed crystal could not be 197 
recovered and redissolved at low temperature to study if the diastereomeric mixture was formed again or 198 
only one diastereomer was present in solution. 199 
 200 
2.4. Ruthenium-catalysed asymmetric transfer hydrogenation 201 
The ruthenium complexes described in the preceding sections were used as catalytic precursors in the 202 
asymmetric reduction of acetophenone by transfer hydrogenation to the chiral alcohol 1-phenylethanol. 203 
The catalytic runs were carried out using a 1% ruthenium complex (C1′, C2′, C3eC6, C8) and 5% of 204 
potassium tertbutoxide as base, in isopropanol as solvent (Scheme 4). 205 
The reactions were carried out under nitrogen atmosphere in  refluxing isopropanol (82 C). This 206 
solvent also plays the role of hydrogen donor, being oxidized to acetone. The catalytic precursor was 207 
initially dissolved in the basic isopropanol solution and stirred for 15 min to form the catalytic Ru-208 
hydride species and then acetophenone was added. At regular intervals (usually 1, 3, 5 and 7 h), aliquots 209 
were extracted and analyzed by gas chromatography, using a chiral column. This allowed the separation 210 
of the starting acetophenone and the two enantiomers of 1-phenylethanol and therefore for each injection 211 
the conversion and enantioselectivity could be immediately determined. For the sake of reproducibility, 212 
for each precursor two catalytic runs were routinely carried out in parallel. 213 
The results of conversion and enantioselectivity obtained with cyclometallated precursors C, along with 214 
those with C’ [15,16] for comparison are given in Table 1. 215 
It has to be pointed out that the reactions were very clean since only the peaks of starting acetophenone 216 
and its reduction products were detected in the GC traces. The table shows that all the precursors were 217 
active in the reaction, leading to full or high conversions at 7 h for most of the cases. 218 
The different activity of coordination compounds C’, in relation to cyclometallated complexes C, show 219 
that the cyclometallation reaction does not occur during the catalytic process. 220 
It can be seen that for the 1-naphthyl- and 9-phenanthrylphosphines, some of the cyclometallated 221 
complexes are more active than the dichloro complexes (cf. entries 3e6 with 8e11) while there is almost 222 
no difference in the case of the complexes with ligand L8 (cf. entries 7 and 12). This effect is especially 223 
relevant for phosphinite L5 because complex C5 is the only one to gives full conversion already in 2 h 224 
(entry 5) while complex C5’ is one of the less active precursors, yielding only 45% conversion at 7 h 225 
(entry 10). It would have been very interesting to explore if the other two cyclometallated complexes 226 
with phosphinite ligands, C7 and C9, give also very active precursors, but unfortunately they could not 227 
be obtained in enough quantity to perform catalysis. Further studies will be directed to obtain those 228 
complexes in better yield and study their catalytic properties. 229 
It should be noted that the enantioselectivity does not improve due to the cyclometallation. Despite the 230 
creation of a new stereocentre at the ruthenium atom most of the systems are completely unselective, 231 
giving racemic 1-phenylethanol. Only precursors C2′ and C4’, containing the bulkiest ligands bearing 232 
the i-Pr group produced some ee, although still very low (entries 2 and 9). 233 
From data obtained so far, it is clear that the cyclometallated complexes containing the 1-naphthyl 234 
group, C3eC5, are the fastest precursors of all the compounds studied. Perhaps the formation of these 235 
metallacycle facilitates the formation of the hydride ruthenium catalyst because it possibly modifies the 236 
reactivity of the metal-chloro bond and/or stabilizes to some extent the hydride derivative. 237 
238 
3. CONCLUSIONS 239 
  240 
In this paper some subtleties of the cycloruthenation reaction have been uncovered. Firstly, the 241 
unsuccessful cyclometallation of ortho-tolyl ligands L1 and L2 contrasts with Zhu's successful 242 
cyclometallation of diisopropyl(ortho-tolyl)phosphine [17]. The fact that the structure of L2 is similar to 243 
Zhu's ligand (the latter has a second isopropyl group and the former a phenyl) highlights the importance 244 
of stereoelectronic effects in the cycloruthenation reaction. Secondly, we have shown that 245 
monophosphines with a polycyclic aromatic substituent are prone to cyclometallate and that the reaction 246 
can be stereoselective, which may be interesting for applications in asymmetric catalysis. We are 247 
currently working to improve the synthesis of the cycloruthenated complexes and study their 248 
organometallic chemistry and catalytic applications. 249 
250 
4. EXPERIMENTAL SECTION 251 
 252 
4.1. General considerations 253 
All compounds were prepared under a purified nitrogen atmosphere by standard Schlenk and vacuum-254 
line techniques. The solvents were obtained from solvent-purification system or purified by standard 255 
procedures and kept under nitrogen. 256 
L1-BH3 and H3BeP(Ph)(MeO)(2-tolyl) were prepared according previously reported methods [18,27]. 257 
Ligands L3-L9 were prepared via phosphine-  boranes following the Jug e-Stephan methodology as we 258 
have previously reported [13a,b,14,16]. 259 
NMR spectra were recorded in CDCl3 at 298 K with Mercury 400 (1H, 13C-{1H}) and Bruker 400 260 
Avance III HD (31P-{1H}) spectrometers. Chemical shifts are given in d values (ppm) relative to SiMe4 261 
(1H and 13C-{1H}), and to 85% H3PO4 (31P-{1H}). Coupling constants are given in Hz and 262 
multiplicity is expressed as: s (singlet), d (doublet), t (triplet), sept (septuplet) and m (multiplet). The IR 263 
spectra were recorded in a Nicolet iS5 spectrophotometer in KBr, and the main absorption bands are 264 
 expressed in cm 1. Highresolution mass spectrometry analyses were performed with electrospray 265 
ionisation. ESI (þ) spectra were acquired either on an LC/MSD-TOF instrument or on a ZQ mass 266 
spectrometer, utilizing a mixture of H2O:CH3CN (1:1, v/v) as the eluent. The GC analyses were 267 
performed on a FID-detector gas chromatograph equipped with a 30m b-Dex 225 column. 268 
 269 
4.2. Synthesis of the ligands 270 
4.2.1. Synthesis of L1, (S)-methylphenyl(2-tolyl)phosphine 271 
The phosphine-borane L1-BH3 (0.34 g, 1.08 mmol) was dissolved in 10 mL of morpholine and stirred 272 
overnight under inert atmosphere. The solventwas removed to dryness leading to a crude brown-yellow 273 
solid, which was redissolved in the minimum volume of anhydrous toluene and purified by column 274 
chromatography (alumina, 120mL of anhydrous toluene). The toluene was removed under vacuum and 275 
the final product was a colourless oil. Yield: 88% (0.17 g). 276 
1H NMR (CDCl3, 400 MHz): d 7.40e7.14 (m, 9H, aromatic), 2.39 (s, 3H, Me), 1.58 (d, J ¼ 4.0 Hz, 3H, 277 
Me). 278 
13C-{1H} NMR (CDCl3, 101 MHz): d 137.5 (s), 132.2 (d, J ¼ 18.8 Hz, aromatic), 130.2 (d, J ¼ 14.2 279 
Hz, aromatic), 128.4 (dd, J ¼ 14.6, 7.9 Hz, aromatic), 126.0 (s, aromatic), 21.2 (d, J ¼ 20.9 Hz, Me), 280 
12.2 (d, J ¼ 13.4 Hz, Me). 31P-  {1H} NMR (CDCl3, 162 MHz): d 36.3 (s). 281 
 282 
4.2.2. Synthesis L2·BH3 (S)-isopropylphenyl(2-tolyl)phosphineborane 283 
The phosphinite-borane H3BeP(Ph)(MeO)(2-tolyl) (0.68 g, 2.8 mmol) was dissolved in 20 mL of 284 
anhydrous diethyl ether and    the solution was cooled to 25 C. 3 equivalents of a solution of iPrLi in 285 
pentane (8.5 mL, 5.92 mmol) were added. Starting    at 20 C, the temperature was sequentially 286 
 increased (10 C every 30 min) to room temperature and the solution was stirred for 1 h. Carefully, 287 
around 20 mL of water were added to the pink solution, which turned white. The suspension was 288 
extracted with diethyl ether (3 x 30 mL) and the combined organic phases were washed with water and 289 
dried with anhydrous sodium sulphate. The suspension was filtered and the solvents were evaporated to 290 
dryness, leading to a colourless oil. Yield: 91% (0.46 g). 291 
MS(EI) m/e: 253.1318 ([M-3H]þ), 279.1448 ([MþNa]þ), 535.2981 ([2 M þ Na]þ). 292 
1H NMR (CDCl3, 400 MHz): d 7.75 (ddd, J ¼ 10.6, 7.7, 1.4 Hz, 1H, aromatic), 7.66e7.54 (m, 2H, 293 
aromatic), 7.49e7.28 (m, 4H, aromatic), 7.23e7.08 (m, 2H, aromatic), 2.78 (m, 1H, CHMe2), 2.18 (s, 294 
3H, Me), 1.24 (dd, J ¼ 16.4, 7.0 Hz, 3H, Me2CH), 1.15 (dd, J ¼ 15.1, 6.9 Hz, 3H, Me2CH), 1.85e0.40 295 
(q, br, 3H, BH3). 296 
31P-{1H} NMR (CDCl3, 162 MHz): d þ25.9 (d, J ¼ 65.9 Hz). 297 
 298 
4.2.3. Synthesis of L2 (S)-isopropylphenyl(2-tolyl)phosphine 299 
The phosphine-borane L2·BH3 (0.20 g, 0.79 mmol) was dissolved in 10 mL of morpholine and stirred 300 
overnight under inert atmosphere. The solvent was evaporated to dryness leading to a crude brown-301 
yellow solid, which was redissolved in the minimum volume of anhydrous toluene and purified by 302 
column chromatography (alumina, 120mL of anhydrous toluene). The toluene was removed under 303 
vacuum and the final product was colourless oil. Yield: 80% (0.15 g). 304 
1H NMR (CDCl3, 400 MHz): d 7.47 (m, 1H), 7.44e7.38 (m, 2H, aromatic), 7.31e7.13 (m, 6H, 305 
aromatic), 2.86 (m, 1H, CHMe2), 2.40 (s, 3H, Me), 1.15 (dd, J ¼ 16.2, 6.9 Hz, 3H,CHMe2), 1.03 (dd, J 306 
¼ 15.2, 6.9 Hz, 3H, CHMe2). 307 
13C-{1H} (CDCl3, 101 MHz): d 143.1 (d, J ¼ 24.3 Hz, aromatic), 137.4 (d, J ¼ 13.9 Hz, aromatic), 308 
136.0 (s, aromatic), 133.7 (d, J ¼ 19.1 Hz, aromatic), 130.9 (s, aromatic), 130.3 (d, J ¼ 4.8 Hz, 309 
aromatic), 128.5 (d, J ¼ 11.3 Hz, aromatic), 128.2 (s, aromatic), 128.1 (s, aromatic), 24.7 (d, J ¼ 8.1 310 
Hz), 21.5 (d, J ¼ 22.2 Hz), 20.0 (d, J ¼ 19.9 Hz), 19.6 (d, J ¼ 18.2 Hz). 311 
31P-  {1H} NMR (CDCl3, 162 MHz): d 11.3 (s).  312 
 313 
4.3. Synthesis of complexes 314 
4.3.1. Synthesis of C1’ 315 
Ligand L1 (162.6 mg, 0.76 mmol), [RuCl2(p-cymene)]2 (214.3 mg, 0.35 mmol) and sodium acetate 316 
(164.1 mg, 2 mmol) were dissolved in 80 mL of methanol and the solution was stirred at room 317 
temperature for 4 h. The solvent was then removed under vacuum, and the residue was chromatographed 318 
on a silica gel column with first CH2Cl2, later with CH2Cl2/Et2O and finally with methanol. The title 319 
product was obtained as an orange solid. Yield 85 mg (20%). 320 
1H NMR (CDCl3, 400 MHz): d 7.95 (ddd, J ¼ 12.8, 7.6, 1.2 Hz, 1H, aromatic), 7.71e7.66 (m, 2H, 321 
aromatic), 7.44e7.32 (m, 5H, aromatic), 7.27e7.24 (m, 1H, aromatic), 5.33 (d, J ¼ 6.4 Hz, 1H, h6-322 
C6H4), 5.25 (d, J ¼ 6 Hz, 1H, h6-C6H4), 5.21 (d, J ¼ 5.6 Hz, 1H, h6-C6H4), 5.10 (d, J ¼ 6 Hz, 1H, h6-323 
C6H4), 2.61 (sept., J ¼ 7.2 Hz, 1H, CHMe2), 2.14 (s, 3H, Me), 2.02 (d, J ¼ 10.8 Hz, 3H, MeP), 1.95 (s, 324 
3H, Me), 0.98 (d, J ¼ 7.2 Hz, 3H, CHMe2), 0.91 (d, J ¼ 7.2 Hz, 3H, CHMe2). 325 
13C-{1H} NMR (CDCl3, 101 MHz): phenyl carbon signals d ¼ 141.36 (d, J ¼ 4.2 Hz, 135.94, 135.50, 326 
135.35, 133.30, 132.89, 132.17 (d, J ¼ 7.0 Hz), 131.58 (d, J ¼ 9.1 Hz), 130.81 (d, J ¼ 2.4 Hz), 129.95 327 
(d, J ¼ 2.4 Hz), 128.40 (d, J ¼ 9.7 Hz), 125.54 (d, J ¼ 11.4 Hz); h6-C6H4 carbon signals d ¼ 107.96, 328 
94.86, 89.97 (d, J ¼ 4.6 Hz), 89.61 (d, J ¼ 4.5 Hz), 86.51 (d, J ¼ 5.9 Hz), 84.96 (d, J ¼ 5.5 Hz); alkyl 329 
carbon signals d ¼ 29.95, 23.10 (d, J ¼ 3.9 Hz), 21.58, 21.43, 17.32, 13.65 (d, J ¼ 35.2 Hz). 330 
31P-{1H} NMR (CDCl3, 162 MHz): d 19.9 ppm. 331 
 332 
4.3.2. Synthesis of C20 333 
The procedure was the same as the one followed to prepare C1. Starting from L2 (182.2 mg, 0.75 334 
mmol). The title product was obtained as an orange solid. Yield 289.3 mg (66%). 335 
IR: 3043, 2957, 2917, 2861, 1630, 1465, 1430, 1378, 1261, 1022, 796, 743, 696, 552, 530.478. 336 
HRMS (ESI): m/z calc. for C26H33PClRuþ [M-Cl]þ 513.1046; found 513.1047. 1H NMR (CDCl3, 400 337 
MHz): d 8.10 (br, 1H, aromatic); 7.60 (br, 1H, aromatic), 7.50e7.29 (m, 7H, aromatic), 5.22 (br., 1H, h6-338 
C6H4), 5.01 (d, J ¼ 6 Hz, 1H, h6-C6H4), 4.81 (br., 1H, h6-C6H4), 4.69 (br., 1H, h6-C6H4), 3.39e3.52 339 
(m, 1H, PCHMe2), 2.81 (sept., J ¼ 14 Hz, 1H, CHMe2), 2.57 (br., 3H, Me), 1.92 (s, 3H, Me), 1.14e1.05 340 
(m, 9H, CHMe2), 0.95e0.85 (br m, 3H, CHMe2). 341 
31P-{1H} NMR (CDCl3, 162 MHz): d 40.0. 342 
 343 
4.3.3. Synthesis of C3 344 
The procedure was the same as the one followed to prepare C1. Starting from ligand L3 (200 mg, 0.8 345 
mmol), the title product was obtained as a brown solid. Yield 70.1 mg (17%). 346 
IR: 1630, 1543, 1482, 1467, 1434, 1384, 1340, 1193, 1099, 1036, 987, 888, 812, 775, 746, 729, 700, 347 
500, 481, 472. 348 
HRMS (ESI): m/z calc. for C27H28PRuþ [M-Cl]þ 485.0966; found 485.0977. 349 
Major isomer: 1H NMR (CDCl3, 400 MHz): d 8.28e8.24 (m, 1H, aromatic), 7.80 (m, 1H, aromatic), 350 
7.52e7.24 (m, 9H, aromatic), 5.71 (d, J ¼ 6 Hz, 1H, h6-C6H4), 5.53 (d, J ¼ 6 Hz, 1H, h6-C6H4), 4.77 351 
(d, J ¼ 6.4 Hz, 1H, h6-C6H4), 4.04 (d, J ¼ 5.6 Hz, 1H, h6-C6H4), 2.45 (sept., J ¼ 14 Hz, CHMe2), 2.17 352 
(d, J ¼ 10.8 Hz, 3H, MeP), 1.73 (s, 3H, Me), 1.09 (d, J ¼ 6.8. Hz, 3H, CHMe2), 0.86 (d, J ¼ 6.8. Hz, 353 
3H, CHMe2). 354 
13C-{1H} NMR (CDCl3, 101 MHz): phenyl carbon signals d ¼ 170.54 (d, J ¼ 13.1 Hz), 140.02, 355 
139.45, 138.86, 138.36, 133.24 (d, J ¼ 15.7 Hz), 130.77 (d, J ¼ 2.5 Hz), 130.10 (d, J ¼ 9.2 Hz), 129.77 356 
(d, J ¼ 2.5 Hz), 128.51 (d, J ¼ 9.5 Hz), 127.7e127.3 (multiplet), 124.58 (d, J ¼ 8.3 Hz), 121.48, h6-357 
C6H4 carbon signals d ¼ 108.6, 97.8, 95.4 (d, J ¼ 5.6 Hz), 91.7 (d, J ¼ 3.4 Hz, major), 90.8 (d, J ¼ 6.1 358 
Hz), 86.7 (d, J ¼ 3.6 Hz); alkyl carbon signals d ¼ 30.2, 23.1, 21.6, 18.42, 13.1 (d, J ¼ 32.0 Hz). 359 
31P-{1H} NMR (CDCl3, 162 MHz): d 56.4. 360 
Minor isomer 1H NMR (CDCl3, 400 MHz): d 8.28e8.24 (m, 1H, aromatic), 7.80 (m, 1H, aromatic), 361 
7.52e7.24 (m, 9H minor, aromatic), 5.97 (d, J ¼ 6 Hz, 2H, h6-C6H4), 5.16 (d, J ¼ 6 Hz, 1H, h6-C6H4), 362 
5.03 (d, J ¼ 5.6 Hz, 1H, h6-C6H4), 2.45 (sept., J ¼ 14 Hz, 1H, CHMe2), 2.16 (d, J ¼ 9.2 Hz, 3H, MeP), 363 
1.87 (s, 3H, Me), 0.95 (d, J ¼ 6.8. Hz, 3H, CHMe2), 0.80 (d, J ¼ 6.8 Hz, 3H, CHMe2). 364 
13C-{1H} NMR (CDCl3, 101 MHz): phenyl carbon signals d ¼ 170.54 (d, J ¼ 13.1 Hz), 139.45, 365 
138.03, 137.52, 134.85, 134.37, 133.30 (d, J ¼ 15.7 Hz), 131.18 (d, J ¼ 9.1 Hz), 130.93 (d, J ¼ 2.5 Hz), 366 
129.40 (d, J ¼ 3.0 Hz, minor), 128.51 (d, J ¼ 9.5 Hz), 127.7e127.3 (multiplet), 124.33 (d, J ¼ 8.3 Hz), 367 
121.37 minor; h6-C6H4 carbon signals d ¼ 107.1, 99.1, 94.6 (d, J ¼ 4.8 Hz), 92.8 (d, J ¼ 4.3 Hz), 87.8 368 
(d, J ¼ 4.8 Hz), 87.2 (d, J ¼ 4.8 Hz) alkyl carbon signals d ¼ 30.41, 22.3, 21.9, 19.4 (d, J ¼ 32.1 Hz), 369 
18.46, 15.25. 370 
31P-{1H} NMR (CDCl3, 162 MHz): d 51.9. 371 
 372 
4.3.4. Synthesis of C4 373 
The procedure was the same as the one followed to prepare C1. Starting from L4 (164.3 mg, 0.59 374 
mmol), the title product was obtained as a brown solid. Yield 52.8 mg (12%).  375 
1H NMR (CDCl3, 400 MHz): d 8.26 (d, J ¼ 6.8 Hz, 1H, aromatic), 7.83 (d, J ¼ 6.4 Hz, 1H, aromatic), 376 
7.78e7.29 (m, 9H, aromatic), 5.66 (d, J ¼ 6.4 Hz, 1H, h6-C6H4), 5.64 (d, J ¼ 7.6 Hz, 1H, h6-C6H4), 377 
4.58 (d, J ¼ 6.4 Hz, 1H, h6-C6H4), 4.08 (d, J ¼ 6 Hz, 1H, h6-C6H4), 2.81 (sept., J ¼ 7.6 Hz, 1H, 378 
CHMe2), 2.32e2.16 (m, 1H, PCHMe2), 1.81 (s, 3H), 1.55 (dd, J ¼ 16.8, 7.2 Hz, 3H, PCHMe2), 1.25 379 
(dd, J ¼ 14.4, 7.2 Hz, 3H, PCHMe2), 0.94 (d, J ¼ 7.0, 3H, CHMe2), 0.52 (d, J ¼ 6.8, 3H, CHMe2). 380 
13C-{1H} NMR (CDCl3, 101 MHz): phenyl carbon signals  d ¼ 170.04 (d, J ¼ 12.8 Hz), 149.10 (d, J ¼ 381 
35.2 Hz), 138.95, 135.75 (d, J ¼ 12.3 Hz), 132.53 (d, J ¼ 15.2 Hz), 130.40 (d, J ¼ 8.0 Hz), 129.82 (d, J 382 
¼ 2.6 Hz), 128.66 (d, J ¼ 2.4 Hz), 128.32, 127.31 (d, J ¼ 8.9 Hz), 126.14, 122.75 (d, J ¼ 7.6 Hz), 383 
120.43; h6-C6H4 carbon signals d ¼ 105.3, 98.8, 93.9 (d, J ¼ 3 Hz), 93.4 (d, J ¼ 5.1 Hz), 90.9 (d, J ¼ 384 
5.8 Hz), 83.7 (d, J ¼ 2.9 Hz); alkyl carbon signals d ¼ 29.1, 26.37 (d, J ¼ 25.5 Hz), 21.6, 20.7, 17.7 (d, J 385 
¼ 3.9 Hz), 17.1. 386 
31P-{1H} NMR (CDCl3, 162 MHz): d 76.6 ppm.  387 
IR: 3039, 2957, 2857,1561,1435,1378,1265,1096,1043, 813, 778, 704, 635, 530. 388 
HRMS (ESI): m/z calc. for C29H32PRuþ [M-Cl]þ 513.1279; found 513.1297. 389 
 390 
4.3.5. Synthesis of C5 391 
The procedure was the same as the one followed to prepare C1. Starting from L5 (226.1 mg, 0.85 392 
mmol), the title product was obtained as a brown solid. Yield 54.3 mg (13%). 393 
IR: 3039, 2922, 2848, 2357, 2335, 1026, 809, 770, 696, 665, 565, 530. 394 
HRMS (ESI): m/z calc. for C27H28OPRuþ [M-Cl]þ 501.0915; found 501.0923. 395 
Major: 1H NMR (CDCl3, 400 MHz): d 8.32 (dd, J ¼ 7.0, 1.1 Hz, 1H, aromatic), 7.89e7.83 (m, 1H, 396 
aromatic), 7.75e7.32 (m, 9H, aromatic), 5.96 (d, J ¼ 6 Hz, 1H, h6-C6H4), 5.94 (d, J ¼ 6.4 Hz, 1H, h6-397 
C6H4), 5.49 (d, J ¼ 6.4 Hz, 1H, h6-C6H4), 5.12 (d, J ¼ 6.4 Hz, 1H, h6-C6H4), 3.47 (d, J ¼ 10.8 Hz, 398 
3H, MeO), 2.45 (m, 1H, CHMe2), 1.96 (s, 3H, Me), 1.13 (d, J ¼ 7.1 Hz, 3H, CHMe2), 0.96 (d, J ¼ 7.2 399 
Hz, 3H, CHMe2). 400 
31P-{1H} NMR (CDCl3, 162 MHz): d 162.6. 401 
Minor: 1H NMR (CDCl3, 400 MHz): d 8.29 (dd, J ¼ 7.0, 1.0 Hz, 1H, aromatic), 7.89e7.83 (m, 1H, 402 
aromatic), 7.75e7.32 (m, 9H, aromatic), 5.86 (d, J ¼ 6 Hz, 1H, h6-C6H4), 5.74 (d, J ¼ 6.0 Hz, 1H, h6-403 
C6H4), 4.83 (d, J ¼ 6.8 Hz, 1H, h6-C6H4), 4.05 (d, J ¼ 6.4 Hz, 1H, h6-C6H4), 3.76 (d, J ¼ 11.6 Hz, 404 
3H, MeO), 2.45 (m, 1H, CHMe2), 1.72 (s, 3H, Me), 1.10 (d, J ¼ 7.2 Hz, 3H, CHMe2), 1.01 (d, J ¼ 6.8 405 
Hz, 3H CHMe2). 406 
31P-{1H} NMR (CDCl3, 162 MHz): d 154.2. 407 
 408 
4.3.6. Synthesis of C6 409 
The procedure was the same as the one followed to prepare C1. Starting from ligand L6 (240.1 mg, 0.8 410 
mmol), the title product was obtained as a brown solid. Yield 324.1 mg (71%). 411 
IR: 3430, 3039, 2957, 2917, 2852, 2356, 1709, 1622, 1557, 1465, 412 
1422,1383,1326,1274,1187,1100,1030, 948, 883, 843, 748, 722, 691, 622, 600, 491, 422. 413 
HRMS (ESI): m/z calc. for C31H30PRuþ [M-Cl]þ 535.1123; found 535.1132. 414 
Major: 1H NMR (CDCl3, 400 MHz): d 8.71 (d, J ¼ 8.3 Hz, 1H, aromatic), 8.40 (d, J ¼ 7.2, 1H, 415 
aromatic), 8.26, (m,1H, aromatic), 7.80e7.30 (m, 10H, aromatic), 5.71 (d, J ¼ 6 Hz, 1H, h6-C6H4), 5.53 416 
(d, J ¼ 6 Hz, 1H, h6-C6H4), 4.77 (d, J ¼ 6.4 Hz, 1H, h6-C6H4), 4.13 (d, J ¼ 6 Hz, 1H, h6-C6H4), 417 
2.40e2.50 (m, 1H, CHMe2), 2.22 (d, J ¼ 10.8 Hz, 3H, MeP), 1.73 (s, 3H, Me), 1.08 (d, J ¼ 7.2 Hz, 3H, 418 
CHMe2), 0.86 (d, J ¼ 6.8. Hz, 3H, CHMe2). 419 
31P-{1H} NMR (CDCl3, 162 MHz): d 56.4. 420 
Minor: 1H NMR (CDCl3, 400 MHz): d 8.69 (d, J ¼ 8.2 Hz, 1H, aromatic), 8.38 (d, J ¼ 7.2, 1H, 421 
aromatic), 8.26, (m,1H, aromatic), 7.80e7.30 (m,10H, aromatic), 5.97 (d, J ¼ 6 Hz, 2H, h6-C6H4), 5.20 422 
(d, J ¼ 6 Hz, 1H, h6-C6H4), 5.06 (d, J ¼ 6.4 Hz, 1H, h6-C6H4), 2.40e2.50 (m, 1H, CHMe2), 2.25 (d, J 423 
¼ 9.6 Hz, 3H, MeP), 1.87 (s, 3H, Me), 0.96 (d, J ¼ 6.8. Hz, 3H, CHMe2), 0.83 (d, J ¼ 6.8 Hz, 3H, 424 
CHMe2). 425 
13C-{1H} NMR (CDCl3, 101 MHz): selected phenyl carbon signals, major and minor derivatives d ¼ 426 
172.15 (d, J ¼ 14.0 Hz), 145.75 (d, J ¼ 36.3 Hz), 141.38, 130.26 (d, J ¼ 9.1 Hz), 129.87 (d, J ¼ 2.5 Hz), 427 
127.41 (d, J ¼ 25.9 Hz), 125.95, 123.25, 116.68; h6-C6H4 carbon signals d ¼ 108.5 (s, major), 107.1 (s, 428 
minor), 99.4 (s, minor), 98.3 (s, major), 95.6 (d, J ¼ 5.6 Hz, major), 94.8 (d, J ¼ 4.8 Hz, minor), 93.2 (d, 429 
J ¼ 4.4 Hz, minor), 92.2 (d, J ¼ 3.6 Hz, major), 90.9 (d, J ¼ 5.9 Hz, major), 87.9 (d, J ¼ 4.9 Hz, minor), 430 
87.6 (d, J ¼ 4.4 Hz, minor), 87.0 (d, J ¼ 3.8 Hz, major); alkyl carbon signals d ¼ 30.4 (s, minor), 30.3 431 
(s, major), 23.2 (s, major), 22.5 (s, minor), 22.1 (s, minor), 21.6 (s, major), 19.2 (d, J ¼ 32.2, minor), 432 
18.5 (minor), 18.4 (major), 13.6 (d, J ¼ 32.0, major). 433 
31P-{1H} NMR (CDCl3, 162 MHz): d 51.2. 434 
4.3.7. Synthesis of C7 435 
The procedure was the same as the one followed to prepare C1. Starting from L7 (258.9 mg, 0.80 436 
mmol), the title product was obtained as a brown solid. Yield 26.8 mg (6%). 437 
IR: 3057, 2957, 2913, 2847, 2361, 2322, 1709, 1613, 1552, 1430, 1383, 1309, 1100, 1035, 948, 800, 438 
757, 687, 609, 570, 465. 439 
HRMS (ESI): m/z calc. for C31H30OPRuþ [M-Cl]þ 551.1072; found 551.1057. 440 
Major: 1H NMR (CDCl3, 400 MHz): d 8.72 (m, 1H, aromatic), 8.62 (d, J ¼ 7.2 Hz, 1H, aromatic), 8.29 441 
(m, 1H, aromatic), 7.85e7.40 (m, 10H, aromatic), 5.93 (d, J ¼ 6.4 Hz, 1H, h6-C6H4), 5.54 (d, J ¼ 6.0 442 
Hz, 1H, h6-C6H4), 5.47 (d, J ¼ 6.4 Hz, 1H, h6-C6H4), 4.22 (d, J ¼ 6.4 Hz, 1H, h6-C6H4), 3.60 (d, J ¼ 443 
11.2 Hz, 3H, MeO), 2.38 (sept., J ¼ 14, 1H, CHMe2), 1.68 (s, 3H, Me), 1.22 (d, J ¼ 7.2 Hz, 3H, 444 
CHMe2), 1.07 (d, J ¼ 6.8 Hz, 3H, CHMe2). 445 
31P-{1H} NMR (CDCl3, 162 MHz): d 158.2. 446 
Minor: 1H NMR (CDCl3, 400 MHz): d 8.72 (m, 1H, aromatic), 8.58 (d, J ¼ 7.2 Hz, 1H, aromatic), 8.29 447 
(m, 1H, aromatic), 7.85e7.40 (m, 10H, aromatic), 6.10 (d, J ¼ 5.2 Hz, 1H, h6-C6H4), 6.0 (d, J ¼ 6.4 Hz, 448 
1H, h6-C6H4), 5.86 (d, J ¼ 5.6 Hz, 1H, h6-C6H4), 5.02 (d, J ¼ 5.2 Hz, 1H, h6-C6H4), 3.61 (d, J ¼ 11.2 449 
Hz, 3H, MeO), 2.46 (sept., J ¼ 14, 1H, minor), 2.38 (sept., J ¼ 14, 1H, CHMe2), 1.93 (s, 3H, Me), 1.24 450 
(d, J ¼ 6.8 Hz, 3H, CHMe2), 0.87 (d, J ¼ 6.8 Hz, 3H, CHMe2). 451 
31P-{1H} NMR (CDCl3, 162 MHz): d 168.4. 452 
 453 
4.3.8. Synthesis of C8 454 
The procedure was the same as the one followed to prepare C1. Starting from Ligand L8 (244.6 mg, 455 
0.75 mmol), the title product was obtained as a brown solid. Yield 32 mg (7%). 456 
IR: 3030, 2957, 2917, 2867, 1709, 1622, 1596, 1574, 1513, 1439, 1387, 1278, 1170, 1113, 1030, 883, 457 
839, 800, 726, 691, 596, 491. HRMS (ESI): m/z calc. per C33H30PRuþ [M-Cl]þ 559.1123; found 458 
559.1133. 459 
Major: 1H NMR (CDCl3, 400 MHz): d 8.91 (s, 1H, aromatic), 8.20e7.30 (m, 12H, aromatic), 6.12 (d, J 460 
¼ 6.4 Hz, 1H, h6-C6H4), 5.68 (d, J ¼ 6 Hz, 1H, h6-C6H4), 4.87 (d, J ¼ 6 Hz, 1H, h6-C6H4), 4.14 (d, J 461 
¼ 6 Hz, 1H, h6-C6H4), 2.55 (sept., J ¼ 6.8 Hz, 1H, CHMe2), 2.29 (d, J ¼ 10.8 Hz, 3H, MeP), 1.80 (s, 462 
3H, Me), 1.13 (d, J ¼ 6.8 Hz, 3H, CHMe2), 0.87 (d, J ¼ 6.8. Hz, 3H, CHMe2). 463 
31P-{1H} NMR (CDCl3, 162 MHz): d 56.7. 464 
Minor: 1H NMR (CDCl3, 400 MHz): d 8.89 (1H, aromatic), 8.20e7.30 (m, 12H, aromatic), 5.87 (d, J ¼ 465 
6.4 Hz, 2H, h6-C6H4), 5.25 (d, J ¼ 6 Hz, 1H, h6-C6H4), 5.16 (d, J ¼ 6.4 Hz, 1H, h6-C6H4), 2.55 (sept., 466 
J ¼ 6.8 Hz, 1H, CHMe2), 2.29 (d, J ¼ 10.8 Hz, 3H, MeP), 1.94 (s, 3H, Me), 0.99 (d, J ¼ 6.8. Hz, 3H, 467 
CHMe2), 0.79 (d, J ¼ 6.8 Hz, 3H, CHMe2). 468 
31P-{1H} NMR (CDCl3, 162 MHz): d 51.9. 469 
 470 
 471 
4.3.9. Synthesis of C9 472 
The procedure was the same as the one followed to prepare C1. Starting from L9 (272.1 mg, 0.80 473 
mmol), the title product was obtained as a brown solid. Yield 20 mg (4%). 474 
IR: 3052, 2965, 2926, 2861, 2357, 2222, 1709, 1613, 1565, 1470, 1435, 1383, 1300, 1257, 1183, 1104, 475 
1030, 843, 735, 696, 604, 574, 522, 457. 476 
HRMS (ESI): m/z calc. for C33H30OPRuþ [M-Cl]þ 575.1072; found 575.1077.Major: 1H NMR 477 
(CDCl3, 400 MHz): d 9.25 (s, 1H, aromatic), 8.13 (dd, J ¼ 6.9, 1.8 Hz, 1H, aromatic), 7.70e6.80 (m, 478 
11H, aromatic), 5.74 (d, J ¼ 6.4 Hz, 1H, h6-C6H4), 5.58 (d, J ¼ 5.6 Hz, 1H, h6-C6H4), 5.14 (d, J ¼ 6 479 
Hz, 1H, h6-C6H4), 3.62 (d, J ¼ 6.0 Hz, 1H, h6-C6H4), 3.27 (d, J ¼ 11.2 Hz, 3H, POMe), 2.43 (m, 1H, 480 
CHMe2), 1.61 (s, 3H, Me), 0.87 (d, J ¼ 7.2 Hz, 3H, CHMe2), 0.51 (d, J ¼ 6.8 Hz, 3H, CHMe2). 481 
31P-{1H} NMR (CDCl3, 162 MHz): d 158.4. 482 
Minor: 1H NMR (CDCl3, 400 MHz): d 9.16 (s, 1H, aromatic), 8.08 (dd, J ¼ 7.1, 1.6 Hz, 1H, aromatic) 483 
7.70e6.80 (m, 11H, aromatic), 5.90 (d, J ¼ 6.8 Hz, 1H, h6-C6H4), 5.83 (d, J ¼ 6.4 Hz, 1H, h6-C6H4), 484 
5.40 (d, J ¼ 6 Hz, 1H, h6-C6H4), 4.52 (d, J ¼ 6.0 Hz, 1H, h6-C6H4), 3.27 (d, J ¼ 11.2 Hz, 3H, major), 485 
2.84 (d, J ¼ 11.2 Hz, 3H, POMe), 2.43 (m, 1H, CHMe2), 1.86 (s, 3H, Me), 0.70 (d, J ¼ 7.2 Hz, 3H, 486 
CHMe2), 0.49 (d, J ¼ 6.8 Hz, 3H, CHMe2). 487 
31P-{1H} NMR (CDCl3, 162 MHz): d 168.1. 488 
 489 
4.4. X-ray crystallography 490 
The X-ray intensity data were measured on a D8 Venture system equipped with a multilayer 491 
monochromator and a Mo microfocus (l ¼ 0.71073 Å). The frames were integrated with the Bruker 492 
SAINT software package using a narrow-frame algorithm. The structure was solved and refined using 493 
the Bruker SHELXTL Software Package [28]. CCDC 1907310e1907312 contain the supplementary data 494 
for this paper. These data can be obtained free of charge from the Cambridge Crystallographic Data 495 
Centre via www.ccdc.cam.ac.uk/ data_request/cif. 496 
 497 
4.5. General procedure for transfer hydrogenation reactions 498 
Transfer hydrogenation reactions of acetophenone were carried out in 100mL Schlenk flasks and in pairs 499 
in order to improve the reproducibility of the data. Under a nitrogen atmosphere, the Schlenk flask was 500 
charged with 0.02 mmol (1%) of the ruthenium complex and 0.10 mmol of potassium tert-butoxide. The 501 
solids were dissolved in 25 mL of 2-propanol and the mixture was left stirring for 15 min at reflux to 502 
activate the catalyst. At this point, 4.0 mmol of acetophenone were added to start the reaction. At regular 503 
intervals of time (1, 3, 5 and 7 h) aliquots were extracted and analysed by gas chromatography, in order 504 
to study the conversion of the reaction and the enantioselectivity of the process. 505 
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Legends to figures 577 
Chart 1. P-stereogenic phosphines. 578 
 579 
Scheme 1. Synthesis of coordination compounds C1′ and C2′. 580 
 581 
Fig. 1. Left: Ball and stick representation of C1′ showing the labelling scheme; hydrogen atoms have 582 
 been omitted for clarity. Selected bond lengths [Å] and angles [ ]: Ru(1)eP(1) 2.3640(6), Ru(1)eCl(1) 583 
2.4103(6), Ru(1)eCl(2) 2.4180(6), P(1)eC(1) 1.829(2); Ru(1)eP(1)eC(1) 111.13(7); P(1)-C(14) 1.820(2). 584 
 585 
Scheme 2. Cyclometallation of L3-L5. 586 
 587 
Scheme 3. Cyclometallation of L6-L9. 588 
 589 
Figure.2 NMR aromatic proton signals of h6-C6H4 fragment (d ¼ 6.4e3.8) of C6 and singlet at d ¼ 590 
5.30 corresponding to dichloromethane. 591 
 592 
Figure.3 Ball and stick representation of C6 showing the labelling scheme; hydrogen atoms have been 593 
omitted for clarity. Selected bond lengths [Å] and angles [°].. 594 
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Table 1 Catalytic results in the asymmetric hydrogenation 645 
 646 
 647 
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